This section is prepared for health professionals only
Pharmaceutical Form
Strengths
Area of Use
Used to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, as well as to prevent deep vein thrombosis (DVT) that leads to pulmonary embolism. (PE)
Pharmaceutical Form
Strengths
Area of Use
Used to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, as well as to prevent deep vein thrombosis (DVT) that leads to pulmonary embolism. (PE)
Pharmaceutical Form
Strengths
Area of Use
Indicated for the treatment of hypertension
Pharmaceutical Form
Strengths
Area of Use
Indicated for the treatment of hypertension
Pharmaceutical Form
Strengths
Area of Use
Indicated for the treatment of hypertension
Pharmaceutical Form
Strengths
Area of Use
Indicated for the treatment of hypertension
Pharmaceutical Form
Strengths
Area of Use
Indicated for the treatment of hypertension
Pharmaceutical Form
Strengths
Area of Use
Used to treat pulmonary arterial hypertension (PAH) by reducing the risk of disease progression and improving exercise capacity
Pharmaceutical Form
Strengths
Area of Use
Used to treat two forms of pulmonary hypertension (PH): chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Pharmaceutical Form
Strengths
Area of Use
Used to treat two forms of pulmonary hypertension (PH): chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Pharmaceutical Form
Strengths
Area of Use
Used to treat two forms of pulmonary hypertension (PH): chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Pharmaceutical Form
Strengths
Area of Use
Used to treat two forms of pulmonary hypertension (PH): chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Pharmaceutical Form
Strengths
Area of Use
Used to treat two forms of pulmonary hypertension (PH): chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Pharmaceutical Form
Strengths
Area of Use
Prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF)
Pharmaceutical Form
Strengths
Area of Use
Prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF)
Pharmaceutical Form
Strengths
Area of Use
Prevention of atherothrombotic events
Pharmaceutical Form
Strengths
Area of Use
Prevention of atherothrombotic events
Pharmaceutical Form
Strengths
Area of Use
Used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH).
Pharmaceutical Form
Strengths
Area of Use
Used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH).
Pharmaceutical Form
Strengths
Area of Use
Tablet
1000 mg
Vascular insufficiencies as in hemorrhoids, arterial insufficiencies that causes pain and cramps in legs and microcirculation insufficiencies as in diabetic neuropathy
Pharmaceutical Form
Strengths
Area of Use
Capsule
500 mg
Vascular insufficiencies as in hemorrhoids, arterial insufficiencies that causes pain and cramps in legs and microcirculation insufficiencies as in diabetic neuropathy
Pharmaceutical Form
Strengths
Area of Use
Hypertension, coronary heart disease
Pharmaceutical Form
Strengths
Area of Use
Hypertension, coronary heart disease
Pharmaceutical Form
Strengths
Area of Use
Hypertension, coronary heart disease
Pharmaceutical Form
Strengths
Area of Use
Retard tablet
400 mg
Occlusive diseases of peripheral arteries, arteriovenous circulatory disorders
Pharmaceutical Form
Strengths
Area of Use
Occlusive diseases of peripheral arteries, arteriovenous circulatory disorders
Cookies are used on our website to enhance your user experience and provide you with personalized services. By clicking the "Accept All" option, you consent to the processing of cookies and their sharing with third parties as outlined on the Privacy Policy page.